Illumina maps out entry into spatial transcriptomics
The company said its spatial technology will run on its current NextSeq and NovaSeq hardware through a new multimodal software platform, with a full commercial release scheduled for 2026.
The company said its spatial technology will run on its current NextSeq and NovaSeq hardware through a new multimodal software platform, with a full commercial release scheduled for 2026.
